I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
FDA Approval Summary: Atezolizumab or Pembrolizumab for the..:
Suzman, Daniel L.
;
Agrawal, Sundeep
;
Ning, Yang-min
...
The Oncologist. 24 (2018) 4 - p. 563-569 , 2018
Link:
https://doi.org/10.1634/theoncologist.2018-0084
RT Journal T1
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy
UL https://suche.suub.uni-bremen.de/peid=cr-10.1634_theoncologist.2018-0084&Exemplar=1&LAN=DE A1 Suzman, Daniel L. A1 Agrawal, Sundeep A1 Ning, Yang-min A1 Maher, V. Ellen A1 Fernandes, Laura L. A1 Karuri, Stella A1 Tang, Shenghui A1 Sridhara, Rajeshwari A1 Schroeder, Jason A1 Goldberg, Kirsten B. A1 Ibrahim, Amna A1 McKee, Amy E. A1 Pazdur, Richard A1 Beaver, Julia A. PB Oxford University Press (OUP) YR 2018 SN 1083-7159 SN 1549-490X JF The Oncologist VO 24 IS 4 SP 563 OP 569 LK http://dx.doi.org/https://doi.org/10.1634/theoncologist.2018-0084 DO https://doi.org/10.1634/theoncologist.2018-0084 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)